Define clear success measures and business cases for the innovation portfolio, including improvements in method robustness, invalid/OOS/OOT rates, turnaround time, throughput, labor intensity, cost, method harmonization, and successful network adoption; use these measures to prioritize investment and stop or redirect low-value efforts early. D. in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, Chemical Engineering, Bioengineering, or a related scientific field with 12+ years of relevant industry experience, or M.S. or B.S. with 18+ years of relevant experience in analytical development, analytical technology, pharmaceutical sciences, or related areas for biologics, vaccines, or advanced therapeutic modalities.